title: Effect of recombinant human erythropoietin on plasma von Willebrand factor in chronic hemodialysis patients.
authors.forename: J
authors.initials: J
authors.lastname: Hársfalvi
authors.forename: Z
authors.initials: Z
authors.lastname: Boda
authors.forename: J
authors.initials: J
authors.lastname: Mikita
authors.forename: I
authors.initials: I
authors.lastname: Kárpáti
authors.forename: G
authors.initials: G
authors.lastname: Kakuk
authors.forename: K
authors.initials: K
authors.lastname: Rák
mesh_terms: D003131:Combined Modality Therapy; D004921:Erythropoietin / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D011994:Recombinant Proteins / Q000494:pharmacology / Q000627:therapeutic use; D006435:Renal Dialysis; D014511:Uremia / Q000097:blood* / Q000188:drug therapy / Q000628:therapy; D014841:von Willebrand Factor / Q000032:analysis*
chemical_list: D011994:Recombinant Proteins; D014841:von Willebrand Factor; D004921:Erythropoietin